Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s471. https://doi.org/10.25251/skin.8.supp.471